Evaluating psychological interventions in a novel experimental human model of anxiety

B. Ainsworth, J.E. Marshall, D. Meron, D.S Baldwin, P. Chadwick, M.R. Munafo, M. Garner

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Inhalation of 7.5% carbon dioxide (CO2) increases anxiety and autonomic arousal and provides a novel experimental model of anxiety with which to evaluate pharmacological and psychological treatments for anxiety. To date several psychotropic drugs have been evaluated using the 7.5% CO2 model, including benzodiazepines, selective serotonin reuptake inhibitors (SSRIs) and serotonin noradrenaline reuptake inhibitors (SNRIs); however, it has yet to be used to evaluate psychological interventions. We compared the effects of two core psychological components of mindfulness-meditation (open monitoring, OM and focused attention, FA) against general relaxation, on subjective, autonomic and neuropsychological outcomes in the 7.5% CO2 experimental model.32 healthy screened adults were randomized to complete 10 minutes of guided open monitoring, focused attention or relaxation, immediately before inhaling 7.5% CO2 for 20 minutes. During CO2-challenge participants completed an eye-tracking measure of attention control and selective attention. Measures of subjective anxiety, blood pressure and heart rate were taken at baseline and immediately following intervention and CO2-challenge.OM and FA practice reduced subjective feelings of anxiety during 20-minute inhalation of 7.5% CO2 compared to relaxation control. OM practice produced a strong anxiolytic effect, whereas the effect of FA was more modest. Anxiolytic OM and FA effects occurred in the absence of group differences in autonomic arousal and eye-movement measures of attention. Our findings are consistent with neuropsychological models of mindfulness-meditation that propose OM and FA activate prefrontal mechanisms that support emotion regulation during periods of anxiety and physiological hyper-arousal. Our findings complement those from pharmacological treatment studies, further supporting the use of CO2 challenge to evaluate future therapeutic interventions for anxiety.
Original languageEnglish
Pages (from-to)117-122
Number of pages6
JournalJournal of Psychiatric Research
Volume63
Early online date12 Feb 2015
DOIs
Publication statusPublished - 1 Apr 2015

Fingerprint

Theoretical Models
Anxiety
Psychology
Arousal
Inhalation
Mindfulness
Meditation
Anti-Anxiety Agents
Emotions
Pharmacology
Psychotropic Drugs
Serotonin Uptake Inhibitors
Eye Movements
Benzodiazepines
Carbon Dioxide
Therapeutics
Heart Rate
Blood Pressure

Keywords

  • Mindfulness
  • Anxiety
  • Experimental Medicine
  • Attention

Cite this

Evaluating psychological interventions in a novel experimental human model of anxiety. / Ainsworth, B.; Marshall, J.E.; Meron, D.; Baldwin, D.S; Chadwick, P.; Munafo, M.R.; Garner, M.

In: Journal of Psychiatric Research, Vol. 63, 01.04.2015, p. 117-122.

Research output: Contribution to journalArticle

Ainsworth, B. ; Marshall, J.E. ; Meron, D. ; Baldwin, D.S ; Chadwick, P. ; Munafo, M.R. ; Garner, M. / Evaluating psychological interventions in a novel experimental human model of anxiety. In: Journal of Psychiatric Research. 2015 ; Vol. 63. pp. 117-122.
@article{ac9fbb8c16ad42cf884a53a75d278961,
title = "Evaluating psychological interventions in a novel experimental human model of anxiety",
abstract = "Inhalation of 7.5{\%} carbon dioxide (CO2) increases anxiety and autonomic arousal and provides a novel experimental model of anxiety with which to evaluate pharmacological and psychological treatments for anxiety. To date several psychotropic drugs have been evaluated using the 7.5{\%} CO2 model, including benzodiazepines, selective serotonin reuptake inhibitors (SSRIs) and serotonin noradrenaline reuptake inhibitors (SNRIs); however, it has yet to be used to evaluate psychological interventions. We compared the effects of two core psychological components of mindfulness-meditation (open monitoring, OM and focused attention, FA) against general relaxation, on subjective, autonomic and neuropsychological outcomes in the 7.5{\%} CO2 experimental model.32 healthy screened adults were randomized to complete 10 minutes of guided open monitoring, focused attention or relaxation, immediately before inhaling 7.5{\%} CO2 for 20 minutes. During CO2-challenge participants completed an eye-tracking measure of attention control and selective attention. Measures of subjective anxiety, blood pressure and heart rate were taken at baseline and immediately following intervention and CO2-challenge.OM and FA practice reduced subjective feelings of anxiety during 20-minute inhalation of 7.5{\%} CO2 compared to relaxation control. OM practice produced a strong anxiolytic effect, whereas the effect of FA was more modest. Anxiolytic OM and FA effects occurred in the absence of group differences in autonomic arousal and eye-movement measures of attention. Our findings are consistent with neuropsychological models of mindfulness-meditation that propose OM and FA activate prefrontal mechanisms that support emotion regulation during periods of anxiety and physiological hyper-arousal. Our findings complement those from pharmacological treatment studies, further supporting the use of CO2 challenge to evaluate future therapeutic interventions for anxiety.",
keywords = "Mindfulness, Anxiety, Experimental Medicine, Attention",
author = "B. Ainsworth and J.E. Marshall and D. Meron and D.S Baldwin and P. Chadwick and M.R. Munafo and M. Garner",
year = "2015",
month = "4",
day = "1",
doi = "10.1016/j.jpsychires.2015.02.001",
language = "English",
volume = "63",
pages = "117--122",
journal = "Journal of Psychiatric Research",
issn = "0022-3956",
publisher = "Elsevier",

}

TY - JOUR

T1 - Evaluating psychological interventions in a novel experimental human model of anxiety

AU - Ainsworth, B.

AU - Marshall, J.E.

AU - Meron, D.

AU - Baldwin, D.S

AU - Chadwick, P.

AU - Munafo, M.R.

AU - Garner, M.

PY - 2015/4/1

Y1 - 2015/4/1

N2 - Inhalation of 7.5% carbon dioxide (CO2) increases anxiety and autonomic arousal and provides a novel experimental model of anxiety with which to evaluate pharmacological and psychological treatments for anxiety. To date several psychotropic drugs have been evaluated using the 7.5% CO2 model, including benzodiazepines, selective serotonin reuptake inhibitors (SSRIs) and serotonin noradrenaline reuptake inhibitors (SNRIs); however, it has yet to be used to evaluate psychological interventions. We compared the effects of two core psychological components of mindfulness-meditation (open monitoring, OM and focused attention, FA) against general relaxation, on subjective, autonomic and neuropsychological outcomes in the 7.5% CO2 experimental model.32 healthy screened adults were randomized to complete 10 minutes of guided open monitoring, focused attention or relaxation, immediately before inhaling 7.5% CO2 for 20 minutes. During CO2-challenge participants completed an eye-tracking measure of attention control and selective attention. Measures of subjective anxiety, blood pressure and heart rate were taken at baseline and immediately following intervention and CO2-challenge.OM and FA practice reduced subjective feelings of anxiety during 20-minute inhalation of 7.5% CO2 compared to relaxation control. OM practice produced a strong anxiolytic effect, whereas the effect of FA was more modest. Anxiolytic OM and FA effects occurred in the absence of group differences in autonomic arousal and eye-movement measures of attention. Our findings are consistent with neuropsychological models of mindfulness-meditation that propose OM and FA activate prefrontal mechanisms that support emotion regulation during periods of anxiety and physiological hyper-arousal. Our findings complement those from pharmacological treatment studies, further supporting the use of CO2 challenge to evaluate future therapeutic interventions for anxiety.

AB - Inhalation of 7.5% carbon dioxide (CO2) increases anxiety and autonomic arousal and provides a novel experimental model of anxiety with which to evaluate pharmacological and psychological treatments for anxiety. To date several psychotropic drugs have been evaluated using the 7.5% CO2 model, including benzodiazepines, selective serotonin reuptake inhibitors (SSRIs) and serotonin noradrenaline reuptake inhibitors (SNRIs); however, it has yet to be used to evaluate psychological interventions. We compared the effects of two core psychological components of mindfulness-meditation (open monitoring, OM and focused attention, FA) against general relaxation, on subjective, autonomic and neuropsychological outcomes in the 7.5% CO2 experimental model.32 healthy screened adults were randomized to complete 10 minutes of guided open monitoring, focused attention or relaxation, immediately before inhaling 7.5% CO2 for 20 minutes. During CO2-challenge participants completed an eye-tracking measure of attention control and selective attention. Measures of subjective anxiety, blood pressure and heart rate were taken at baseline and immediately following intervention and CO2-challenge.OM and FA practice reduced subjective feelings of anxiety during 20-minute inhalation of 7.5% CO2 compared to relaxation control. OM practice produced a strong anxiolytic effect, whereas the effect of FA was more modest. Anxiolytic OM and FA effects occurred in the absence of group differences in autonomic arousal and eye-movement measures of attention. Our findings are consistent with neuropsychological models of mindfulness-meditation that propose OM and FA activate prefrontal mechanisms that support emotion regulation during periods of anxiety and physiological hyper-arousal. Our findings complement those from pharmacological treatment studies, further supporting the use of CO2 challenge to evaluate future therapeutic interventions for anxiety.

KW - Mindfulness

KW - Anxiety

KW - Experimental Medicine

KW - Attention

U2 - 10.1016/j.jpsychires.2015.02.001

DO - 10.1016/j.jpsychires.2015.02.001

M3 - Article

VL - 63

SP - 117

EP - 122

JO - Journal of Psychiatric Research

JF - Journal of Psychiatric Research

SN - 0022-3956

ER -